This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Strannegård, O. Articles by Lycke, E. Search for Related Content PubMed PubMed Citation Articles by Strannegård, O. Articles by Lycke, E.

 Previous Article  |  Next Article 

Infect Immun. 1972 May; 5(5): 769-774
Copyright © 1972 American Society for Microbiology. All Rights Reserved.

Effect of Antithymocyte Serum on Experimental Toxoplasmosis in Mice

Department of Virology, Institute of Medical Microbiology, University of Göteborg, Sweden

ABSTRACT

The effect of antithymocyte serum (ATS) on mice infected with high-virulent or low-virulent strains of Toxoplasma gondii was studied. Treatment with ATS reduced the survival time of mice infected with high-virulent Toxoplasma and aggravated the disease; treatment prolonged parasitemia in animals infected with low-virulent Toxoplasma. Although ATS adversely affected the humoral antibody response, its main effect on toxoplasmosis was probably due to depression of cell-mediated immunity. ATS appeared to be able to activate chronic Toxoplasma infection, but this effect was much less pronounced than that on acquisition of immunity. The results suggest that Toxoplasma infection should be routinely looked for in patients treated with antilymphocyte serum.